Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes
Sponsor
Vienna Institute for Research in Ocular Surgery (Other)
Overall Status
Recruiting
CT.gov ID
NCT03583632
Collaborator
(none)
20
1
46.9
0.4
Study Details
Study Description
Brief Summary
Improvement in visual acuity and retinal anatomy one year after surgery is assessed and compared to data preoperative and 3 months after surgery
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Improvement in visual acuity and retinal anatomy (documented by optical coherence tomography) one year after surgery is assessed and compared to data preoperative and 3 months after surgery. Aim of the study is to examine possible improvements of surgical outcomes in the period up to the one year follow-up.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
20 participants
Observational Model:
Case-Control
Time Perspective:
Other
Official Title:
Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes
Actual Study Start Date
:
Feb 1, 2018
Anticipated Primary Completion Date
:
Dec 31, 2021
Anticipated Study Completion Date
:
Dec 31, 2021
Outcome Measures
Primary Outcome Measures
- visual acuity [3 minutes]
visual acuity testing with EDTRS charts
Secondary Outcome Measures
- optical coherence tomography [3 minutes]
optical coherence tomography generates slides of the retinal anatomy with light
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- vitrectomy with Membrane Peeling due to an epiretinal membrane
Exclusion Criteria:
- none
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna | Vienna | Austria | 1140 |
Sponsors and Collaborators
- Vienna Institute for Research in Ocular Surgery
Investigators
- Principal Investigator: Oliver Findl, MD, Prof, VIROS at Hanuschkrankenhaus Vienna
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Prim. Prof. Dr. Oliver Findl, MBA,
Head of the Department of Ophthalmology, Professor, Principal Investigator,
Vienna Institute for Research in Ocular Surgery
ClinicalTrials.gov Identifier:
NCT03583632
Other Study ID Numbers:
- ERM 1year follow-up
First Posted:
Jul 11, 2018
Last Update Posted:
Jan 12, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: